Intercept Pharmaceuticals, Inc.
Intercept Pharmaceuticals, Inc. (ICPT) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · ICPT · as of Sep 30, 2023
Ownership Breakdown
166
Institutional Holders
▲ 24 vs Q2
$724.60M
Total Inst. Value
▲ $337.17M vs Q2
41.83M
Shares Outstanding
freeFloat 82.47%
39.01M
13F Shares Held
▲ 3.98M vs Q2
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
ICPT largest shareholders · institutional ownership
Q3 2023 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
BLACKROCK INC. pharmaceutical preparations | 4.21M | 10.10% | 10.10% | $78.11B | Nov 13, 2023 | ▼ 184.2K |
STATE STREET CORP pharmaceutical preparations | 3.20M | 7.66% | 7.66% | $59.29B | Nov 14, 2023 | ▼ 982.4K |
UBS GROUP AG pharmaceutical preparations | 3.00M | 7.19% | 7.19% | $55.60B | Nov 9, 2023 | ▲ 1.64M |
MAGNETAR FINANCIAL LLC pharmaceutical preparations | 2.41M | 5.77% | 5.77% | $44.63B | Nov 14, 2023 | NEW |
ALPINE ASSOCIATES MANAGEMENT INC. pharmaceutical preparations | 2.20M | 5.28% | 5.28% | $40.85B | Nov 8, 2023 | NEW |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) pharmaceutical preparations | 2.08M | 4.98% | 4.98% | $38.52B | Nov 14, 2023 | — held |
VANGUARD GROUP INC pharmaceutical preparations | 2.07M | 4.96% | 4.96% | $38.40B | Dec 18, 2023 | ▼ 2.62M |
JEFFERIES FINANCIAL GROUP INC. pharmaceutical preparations | 2.00M | 4.79% | 4.79% | $37.08B | Nov 14, 2023 | NEW |
ALLIANCEBERNSTEIN L.P. pharmaceutical preparations | 1.54M | 3.70% | 3.70% | $28.61B | Nov 14, 2023 | ▲ 1.48M |
PICTET ASSET MANAGEMENT HOLDING SA pharmaceutical preparations | 1.21M | 2.89% | 2.89% | $22.34B | Nov 14, 2023 | NEW |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q3 2023 vs prior quarter
Q3 2023
17
Increased
+5.88M shares15
New Positions
first time holders16
Decreased
−5.75M shares0
Sold Out
fully exitedNet shares change (top 50)
+132.6K
+5.88M / −5.75M
Net new holders
+16
15 new / 0 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
ICPT insider trading · insider activity
Source: SEC Form 4
0
Buy transactions
1
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 8,111 | $19.00 | $154.1K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 2,174 | $82.25 | $178.8K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 2,966 | $72.74 | $215.7K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 12,089 | $17.08 | $206.5K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 12,790 | $16.82 | $215.1K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 12,547 | $9.17 | $115.1K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 275 | $210.36 | $57.8K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 2,748 | $85.12 | $233.9K | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | U-Tender | 640,688 | $19.00 | $12.17M | 0 | Form 4 ↗ |
AKKARAJU SRINIVAS director | Nov 8, 2023 | D-Return | 1,750 | $183.62 | $321.3K | 0 | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Intercept Pharmaceuticals, Inc. (ICPT) is primarily owned by institutional investors, who hold approximately 93.3% of total shares outstanding. Company insiders own approximately 17.53%, while retail and public investors account for the remaining 0.00%.
The largest institutional shareholder of Intercept Pharmaceuticals, Inc. is BLACKROCK INC., holding approximately 4.21 million shares — equal to 10.10% of outstanding shares — as of September 30, 2023.
A total of 166 institutional investors currently hold ICPT stock, with a combined institutional value of approximately $724,597,201 as of the most recent 13F filing period.
Frequently asked questions
ICPT ownershipIntercept Pharmaceuticals, Inc. (ICPT) is primarily owned by institutional investors, who hold approximately 93.3% of shares. The largest shareholder is BLACKROCK INC. with a 10.10% stake. Company insiders hold 17.53%. Data sourced from SEC Form 13F as of September 30, 2023.